This RSS feed URL is deprecated
Trading in the News: Investors Keen on Arbutus Biopharma Corporation (NASDAQ:ABUS) as it Makes Headlines With ... - The Coin Guild
Arbutus Biopharma Corporation (NASDAQ:ABUS) closed at $4.77 after the last trading day, drawing interest from investors and traders. The stock trades on NSDQ in the Medical sector and Medical – Biomedical and Genetics industry. Outstanding shares are ...
Arbutus Biopharma Corporation (NasdaqGS:ABUS), Absolute ... - Hartsburg News
Here will take a quick scan of Earnings Yield information on shares of Arbutus Biopharma Corporation (NasdaqGS:ABUS). Currently, the Earnings to Price ...
Which Way Are Insiders Leaning With Arbutus Biopharma Corporation (NASDAQ:ABUS)? - Bay City Observer
Insiders at Arbutus Biopharma Corporation (NASDAQ:ABUS) have decreased their position in the stock by -3.03% over the past 6 months, according to the latest SEC Filings. Insiders now own ... University of Michigan professor and noted insider trading ...altro »
Arbutus Biopharma Target of Unusually High Options Trading (NASDAQ:ABUS) - PressOracle
Arbutus Biopharma Corp (NASDAQ:ABUS) was the target of unusually large options trading on Thursday. Stock traders bought 1,559 call options on the company. This represents an increase of 975% compared to the typical daily volume of 145 call options.altro »
Arbutus Biopharma Corporation (ABUS) has a value of $4.38 per share While Hemispherx Biopharma, Inc. (HEB) is ... - Stocks Gallery
In recent session, Arbutus Biopharma Corporation (ABUS) traded 0.16 million shares at hands. This volume capacity is dissimilar from 3 months average volume. Currently, the stock has a 3 months average volume of 0.43 million. Investors may be trying to ...
Arbutus Biopharma (ABUS) Upgraded to Buy at Zacks Investment Research - Fairfield Current
According to Zacks, “Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a portfolio of drug candidates for chronic hepatitis B infection. The Company's products include TKM-HBV ...altro »
Watch List Healthcare Stock Buzz: Arbutus Biopharma Corporation (ABUS) - Stock Digest (press release)
Arbutus Biopharma Corporation (ABUS) stock has been separated -29.38% away from the 200-day MA. Tracking current stock price levels in relation to some other popular moving averages, we have noted that the stock is trading -33.99% away from the ...
Arbutus to Report Third Quarter 2018 Financial Results - GlobeNewswire (press release)
WARMINSTER, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third quarter financial results ...
New Research Coverage Highlights Arbutus Biopharma, Tata Motors, Core-Mark Holding, Tenaris SA, Addus ... - GlobeNewswire (press release)
New Research Coverage Highlights Arbutus Biopharma, Tata Motors, Core-Mark Holding, Tenaris S.A, Addus HomeCare, and ZTO Express (Cayman) — Consolidated Revenues, Company Growth, and Expectations for 2018 ... all current investors, traders, and ...altro »
Stock under Close Observation: Packaging Corporation of America (PKG), Arbutus Biopharma Corporation (ABUS) - News Stays On Track (press release)
Packaging Corporation of America (PKG) Daily Performance: Packaging Corporation of America (PKG) stock negotiated recent volume of 664671 shares in recent trading session on Friday Dated NOVEMBER 09, 2018. The stock average capacity of shares ...